"Designing Growth Strategies is in our DNA"

Abdominal Aortic Aneurysm Repair Market Size, Share, and Industry Analysis By Site (Infrarenal Abdominal Aortic Aneurysm (IAAA) and Pararenal Abdominal Aortic Aneurysm (PAAA)), By Product (Stent Graft and Catheters), By Treatment Type (Open Surgical Repair (OSR) and Endovascular Aneurysm Repair (EVAR)), By End-user (Hospitals and ASCs, Specialty Clinics, and Others), and Regional Forecast, 2026-2034

Last Updated: December 01, 2025 | Format: PDF | Report ID: FBI111539

 

KEY MARKET INSIGHTS

The global abdominal aortic aneurysm repair market size was valued at USD 5.18 billion in 2025. The market is projected to grow from USD 5.83 billion in 2026 to USD 15.09 billion by 2034, exhibiting a CAGR of 12.61% during the forecast period.

The global abdominal aortic aneurysm repair market boom is being driven via developing incidence of aortic aneurysms due to growing old populations, growing instances of excessive blood stress, and life-associated risk factors alongside smoking and obesity. Advancements in minimally invasive methods, which include endovascular aneurysm repair (EVAR), have higher affected character effects, reducing health facility stays and healing times. Additionally, developing consciousness, advanced diagnostic abilities, and authorities obligations promoting early detection similarly propel market growth. Increasing healthcare prices, the developing geriatric populace, and the developing adoption of technologically advanced grafts and stents are also key factors influencing the market's boom globally.

According to the National Center for Biotechnology Information (NCBI), the proportion of octogenarians undergoing intact AAA repair increased from 16.2% in 2001 to 28.4% in 2021.

Abdominal Aortic Aneurysm Repair Market Driver

Increasing Prevalence of Abdominal Aortic Aneurysms Drive the Market Growth

The growing occurrence of Abdominal Aortic Aneurysms (AAAs), specially a number of the ageing population, is a major driver of the AAA repair market. As human beings age, the risk of aortic wall weakening increases because of factors inclusive of hypertension, smoking, and genetic predisposition. The developing amount of geriatric sufferers international has heightened the call for powerful and advanced restore answers, at the side of endovascular aneurysm restore (EVAR) and open surgical methods.

Abdominal Aortic Aneurysm Repair Market Restraint

High Cost of Procedures Limiting Market Accessibility

The immoderate price of Abdominal Aortic Aneurysm (AAA) repair techniques poses a big restraint on market growth, specifically in low- and center-earnings regions. Advanced treatments collectively with endovascular aneurysm repair (EVAR) incorporate highly-priced grafts, stents, and imaging technology, making them a good deal much less on hand for uninsured or financially restrained sufferers. Additionally, the charge of hospitalization, postoperative care, and take a look at-up imaging in addition will increase the overall monetary burden.

Abdominal Aortic Aneurysm Repair Market Opportunity

Emerging Markets Expansion Driving Growth Opportunities

Developing international places with improving healthcare infrastructure gift huge possibilities for the Abdominal Aortic Aneurysm (AAA) repair market. As healthcare systems in regions which includes Asia-Pacific, Latin America, and the Middle East make bigger, there's developing investment in cutting-edge scientific technologies and minimally invasive techniques such as endovascular aneurysm repair (EVAR). Expanding insurance coverage, growing disposable incomes, and authorities tasks to decorate cardiovascular care similarly drive market expansion.

Segmentation

By Site

By Product

By Treatment Type

By End User

By Geography

  • Infrarenal Abdominal Aortic Aneurysm (IAAA)
  • Pararenal Abdominal Aortic Aneurysm (PAAA)
  • Stent Graft
  • Catheters
  • Open Surgical Repair (OSR)
  • Endovascular Aneurysm Repair (EVAR)
  • Hospitals and ASCs,
  • Specialty Clinics 
  • Others
  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Spain, Italy, Scandinavia, and the Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)
  • South America (Brazil, Columbia, and the Rest of Latin America)
  • Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)

Key Insights

The report covers the following key insights:

  • Major Market Drivers, Trends, and Investment Opportunities
  • Business Strategies Adopted by Key Players and Key Industry Developments (Mergers, Acquisitions, and Partnerships)
  • Overview: Regulatory Scenario and Government Policies
  • Rising Prevalence of Aneurysms – The increasing incidence of abdominal aortic aneurysms, particularly among the aging population
  • Shift Toward Minimally Invasive Procedures – Endovascular aneurysm repair (EVAR) is gaining traction over open surgery due to reduced recovery time and lower risks

Analysis by Site

By site, the market is split into Infrarenal Abdominal Aortic Aneurysm (IAAA) and Pararenal Abdominal Aortic Aneurysm (PAAA).

Infrarenal Abdominal Aortic Aneurysms (IAAA) account for a sizeable share of the market owing to the use of demand for powerful restore solutions. The growing incidence amongst growing antique populations and excessive-chance humans necessitates advanced treatments such as endovascular aneurysm restore (EVAR). Technological improvements in graft layout, advanced imaging strategies, and developing consciousness further increase market growth via using enhancing treatment accessibility, lowering headaches, and enhancing affected person consequences globally.

Analysis by Product

Based on product, the market is subdivided into stent graft and catheters.

Stent grafts play a essential feature in the Abdominal Aortic Aneurysm (AAA) restore market, particularly with the developing adoption of endovascular aneurysm repair (EVAR). Their minimally invasive nature, shorter restoration instances, and decreased trouble fees motive them to a favored preference over open surgical treatment. Continuous improvements in graft substances, flexibility, and durability further decorate their effectiveness, expanding market possibilities worldwide.

Analysis by Treatment Type

By treatment type, the market is fragmented into Open Surgical Repair (OSR) and Endovascular Aneurysm Repair (EVAR).

Open Surgical Repair (OSR) stays a critical remedy choice in the Abdominal Aortic Aneurysm (AAA) restore market, specifically for complicated or ruptured aneurysms incorrect for endovascular aneurysm restore (EVAR). Despite the upward push of minimally invasive procedures, OSR remains considerably used because of its lengthy-time period sturdiness and effectiveness. It is particularly important in areas with limited get right of entry to superior EVAR generation.

Analysis by End User

By end user, the market is split into hospitals and ASCs, specialty clinics, and others.

Hospitals and Ambulatory Surgical Centers (ASCs) play a critical role within the Abdominal Aortic Aneurysm (AAA) repair market with the useful resource of offering advanced surgical facilities, skilled professionals, and put up-operative care. The developing type of AAA instances has driven call for specialized remedy centers prepared with present day era like endovascular aneurysm repair (EVAR) and open surgical restore (OSR).

Regional Analysis

To gain extensive insights into the market, Download for Customization

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America dominates the Abdominal Aortic Aneurysm (AAA) repair market due to high disease prevalence, superior healthcare infrastructure, and large adoption of endovascular aneurysm repair (EVAR). Favorable compensation rules, robust R&D investments, and technological innovations in stent grafts similarly pressure market growth.

Europe's AAA restore market is increasing due to growing geriatric populations, government-funded healthcare structures, and growing adoption of minimally invasive strategies. Countries such as Germany, the United Kingdom, and France lead in superior aneurysm remedies, supported by way of the usage of stringent regulations making sure high-quality clinical gadgets. Additionally, growing investments in cardiovascular healthcare and developing attention campaigns sell early detection, boosting call for each endovascular aneurysm restore (EVAR) and open surgical restore (OSR).

The Asia Pacific AAA restore market is witnessing fast increase due to enhancing healthcare infrastructure, rising disposable earning, and growing recognition of aortic aneurysms. Countries such as China, Japan, and India are investing in advanced medical technology and growing screening packages. The developing geriatric population and growing incidence of risk elements like high blood pressure and smoking further force call for AAA restore strategies, specifically minimally invasive treatments which include EVAR.

Key Players Covered

The report includes the profiles of the following key players:

  • W. L. Gore & Associates, Inc. (U.S.)
  • Medtronic (Ireland)
  • Endologix LLC. (U.S.)
  • Cook (U.S.)
  • Cordis (U.S.)
  • Lombard Medical (U.K.)
  • Terumo Corporation (Japan)
  • MicroPort Scientific Corporation (China)
  • JOTEC GmbH (Artivion, Inc.) (Germany)

Key Industry Developments

  • July 2021: Endologix announced that the U.S. Food and Drug Administration granted Breakthrough Device Designation for its ChEVAS (Chimney EndoVascular Aneurysm Sealing) System, meant for the endovascular treatment of complex AAAs.
  • April 2021: Endologix LLC obtained PQ Bypass, a systematic era business enterprise, to increase its product portfolio for the treatment of vascular diseases, which includes AAAs.
  • March 2021: Cook Medical delivered the Zenith Fenestrated+ Endovascular Graft, designed to deal with patients with complicated AAAs.


  • 2021-2034
  • 2025
  • 2021-2024
  • 128
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann